Article Details
Retrieved on: 2023-09-11 03:53:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Suptavumab is another human monoclonal antibody developed for RSV-disease prophylaxis. However, in August 2017 Regeneron Pharmaceuticals discontinued ...
Article found on: www.dovepress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here